L. Kabasakal Et Al. , "The role of PSMA PET/CT imaging in restaging of prostate cancer patients with low prostate-specific antigen levels," NUCLEAR MEDICINE COMMUNICATIONS , vol.38, no.2, pp.149-155, 2017
Kabasakal, L. Et Al. 2017. The role of PSMA PET/CT imaging in restaging of prostate cancer patients with low prostate-specific antigen levels. NUCLEAR MEDICINE COMMUNICATIONS , vol.38, no.2 , 149-155.
Kabasakal, L., Demirci, E., Nematyazar, J., Akyel, R., Razavi, B., Ocak, M., ... Aygun, A.(2017). The role of PSMA PET/CT imaging in restaging of prostate cancer patients with low prostate-specific antigen levels. NUCLEAR MEDICINE COMMUNICATIONS , vol.38, no.2, 149-155.
Kabasakal, Levent Et Al. "The role of PSMA PET/CT imaging in restaging of prostate cancer patients with low prostate-specific antigen levels," NUCLEAR MEDICINE COMMUNICATIONS , vol.38, no.2, 149-155, 2017
Kabasakal, Levent Et Al. "The role of PSMA PET/CT imaging in restaging of prostate cancer patients with low prostate-specific antigen levels." NUCLEAR MEDICINE COMMUNICATIONS , vol.38, no.2, pp.149-155, 2017
Kabasakal, L. Et Al. (2017) . "The role of PSMA PET/CT imaging in restaging of prostate cancer patients with low prostate-specific antigen levels." NUCLEAR MEDICINE COMMUNICATIONS , vol.38, no.2, pp.149-155.
@article{article, author={Levent Kabasakal Et Al. }, title={The role of PSMA PET/CT imaging in restaging of prostate cancer patients with low prostate-specific antigen levels}, journal={NUCLEAR MEDICINE COMMUNICATIONS}, year=2017, pages={149-155} }